BOARD OF DIRECTORS
BIPOLAR DEPRESSION IN PATIENTS WITH ACUTE SUICIDAL IDEATION/BEHAVIOR (ASIB)
RESOURCES FOR PATIENTS, FAMILY & FRIENDS
PATIENT STORIES THAT INSPIRE US
MECHANISM OF ACTION
NRX-100 / NRX-101
IN THE NEWS
Suicide is a national epidemic. We need to treat it like one.
View CEO, Prof. Jonathan Javitt, MD's latest OpEd at www.washingtonpost.com
Neurorx, inc. is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders
Recent scientific breakthroughs suggest the chemical target for suicidality in bipolar depression may be localized in the brain’s NMDA receptor
The first oral therapeutic being developed for the treatment of acute suicidal crisis in bipolar disorder
View the latest press releases and media coverage for NeuroRx
© 2016 NeuroRx, Inc.
*These drugs are investigational and not approved by the US FDA